JG
EPZM

Jefferies Group’s Epizyme, Inc EPZM Stock Holding History

Jefferies Group’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,828
Closed -$199K – 2187
2021
Q1 		$199K Buy
22,828
+5,237
+30% +$54.2K ﹤0.01% 1360
2020
Q4 		$191K Buy
+17,591
New +$217K ﹤0.01% 1382
2020
Q3 		– Sell
-32,682
Closed -$525 – 1682
2020
Q2 		$525 Buy
32,682
+27,682
+554% +$483K 0.01% 906
2020
Q1 		$78K Buy
+5,000
New +$107K ﹤0.01% 1828
2019
Q4 		– Sell
-30,877
Closed -$458K – 3196
2019
Q3 		$318K Sell
30,877
-9,323
-23% -$118K 0.01% 2150
2019
Q2 		$505K Buy
+40,200
New +$517K 0.01% 1664
2019
Q1 		– Sell
-20,642
Closed -$127K – 2770
2018
Q4 		$127K Buy
+20,642
New +$158K ﹤0.01% 1929

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return